Clinical Trial Update: Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sequential transarterial chemoembolization (TACE) and stereotactic body radiation therapy (SBRT) followed by immunotherapy for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: The University of Hong Kong | Conditions: HCC | Phase 2 | Status: COMPLETED